Methods for estimating the cord blood (CB) inventory size required vary according to the ethnic diversity of the HLA, degree of HLA matching and HLA-typing resolution. We estimated the CB inventory size required using 7190 stored CB units (CBU) and 2450 patients who were awaiting or underwent allogeneic hematopoietic stem cell transplantation. With high-resolution typing of HLA-A, B and DRB1, 94.6% of Korean patients could find CBUs in 100 000 CBUs with a 5/6 match, and 95.7% could find CBUs in 5000 CBUs with a 4/6 match. With low-resolution typing of HLA-A and B and high-resolution typing of leukocyte antigen-DRB1, 95% of patients could find CBUs in 50 000 CBUs with a 5/6 match, and 96.7% could find CBUs in 3000 CBUs with a 4/6 match. With additional high-resolution typing for HLA-A and B, which could improve transplantation outcome, the size of the CB inventory would need to increase twofold for Koreans. 
INTRODUCTION
Umbilical cord blood (CB) is considered to be a reasonable alternative to BM or G-CSF-mobilized PBSC. CB is better than BM in terms of its rapid availability, 1 tolerance for HLA mismatching and lower probability of or milder GVHD. 2 In 2012, the number of public CB banks in Korea was 10 out of 17 government-review-andevaluation completed CB Banks with the help of public recognition of CB. 3 The growing view of CB as a public health resource resulted in the legislation of the Cord Blood Management and Research Act in July 2011, 4 which unified the available CB data for searching convenience, enforced quality cutoff for cryopreserved CB units (CBU) and supported translational research with nonconforming units. Following enactment of this act, three governmentassigned public CB banks were established and operated in Korea.
The CB inventory size required should be estimated for each ethnic group because the frequency of HLA and number of total nucleated cells in CB vary among different ethnic groups. 5, 6 In addition, the required inventory size depends on the resolution of HLA typing. A recent retrospective study showed that highresolution matching lowered the prevalence of grade III to IV GVHD in double cord blood transplantation (CBT), 7 which supports the need for high-resolution HLA typing of HLA-A, B and DRB1 in CBT. Therefore, we estimated our required CB inventory size based on high-resolution typing of HLA-A, B and DRB1.
METHODS AND RESULTS
To determine the possible donor HLA types, we enrolled 7190 CBUs with high-resolution typing results for HLA-A, -B and DRB1 donated to a CHA Medical Center Cord Blood Bank from June 2006 to December 2012. In order to match probabilities, we used 2450 patients with high-resolution typing results for HLA-A, B and DRB1 who were awaiting or underwent hematopoietic stem cell transplantation (SCT) from January 2006 to March 2013 from two transplantation institutions. This study was approved by the Institutional Review Board of the Seoul National University Boramae Hospital (16-2013-77) .
For CBUs, the SeCore A, B and DRB1 Locus Sequencing Kit (Invitrogen, Brown Deer, WI, USA) or AlleleSEQR HLA-A, B and DRB1 PCR/Sequencing Kit (Abbott Laboratories, Abbott Park, IL, USA) was used. For patients, HLA data were pooled from the two independent transplantation institutions. HLA typing was performed using the AlleleSEQR HLA Sequencing kit (Abbott Laboratories) in one institution, and heterozygous amplification and sequencing of the complete exons 2, 3 of HLA-A,-B and exon 2 of HLA-DRB1 as previously reported in another institution. [8] [9] [10] To estimate the CB inventory size needed, we used a statistical analysis as previously described. 11 We used a three-step approach. In step 1, Hardy-Weinberg equilibrium tests and linkage disequilibrium were assessed for HLA-A, B and DRB1 genotypes. HLA-A-B-DRB1 haplotypes for 7190 CBUs were inferred from the Expectation-Maximization algorithm. In step 2, from the combinations of haplotypes with frequencies greater than 0.00695%, HLA DNA genotype patterns were obtained. In step 3, to compute the matching probabilities for 4/6, 5/6 and 6/6 matching for 2450 patients' HLA phenotypes, a bootstrap method was applied. From the hypothetically estimated donor pool in stage 2, a variety of donor sizes were collected from 10 to 500 000, and 100 bootstrap datasets (replications) were generated for each donor size. All statistical analyses were conducted using the functions of the gap and genetics packages in R version 2.15.1 (http://www. r-project.org).
Allele groups were in Hardy-Weinberg equilibrium states for each HLA-A, B and DRB1. The alleles observed from 7190 CBUs are listed in Supplementary Table 1 . With high-resolution typing, 8142 HLA haplotypes were generated (Supplementary Table 2 ). The top 1657 HLA-A, B and DRB1 haplotypes had a frequency of at least 0.00695% and a cumulative frequency of 96.0%. From combinations of 1657 haplotypes, 1128 578 HLA genotypes were generated. With low-resolution typing of HLA-A and B and highresolution typing of HLA-DRB1, 5278 HLA haplotypes were generated. The top 1343 HLA-A, B and DRB1 haplotypes had a frequency of at least 0.00695% and a cumulative frequency of 97.5% (Supplementary Table 3 ). From combinations of 1343 haplotypes, 701 507 HLA genotypes were generated.
On the basis of high-resolution typing of HLA-A, B and DRB1, we created various donor sizes (10-500 000) from the 1128 578 hypothetical donor. Each donor size was replicated 100 times, and HLA matching was performed with patients ( Figure 1) . With an inventory size of 500 000 CBUs, only 42% of the patients would find a CBU with a 6/6 match. With 100 000 CBUs, 94.6% of the patients would find a CBU with a 5/6 match. With 5 000 CBUs, 95.7% of the patients would find a CBU with a 4/6 match.
On the other hand, based on low-resolution typing of HLA-A and B and high-resolution typing of HLA-DRB1, we could make various donor sizes (10-500 000) from the 701 507 hypothetical donor pools (Figure 2) . With an inventory size of 500 000 CBUs, 61% of the patients could find a CBU with a 6/6 match. With 50 000 CBUs, 95% of the patients could find a CBU with a 5/6 match. With 3000 CBUs, 96.7% of the patients could find a CBU with a 4/6 match.
DISCUSSION
The appropriate CB inventory size depends on the racial genetic polymorphism of HLA. Considering a 5/6 match with lowresolution typing of HLA-A and B and high-resolution typing of HLA-DRB1, approximately 20 000 CBUs were required to identify Cord blood inventory 10000 1e+05 5e+05 Figure 1 . The probability of finding matched CBU based on increasing inventory size (10-500 000) from 1128 578 hypothetical donor types for 2450 patients who received or were awaiting unrelated allogeneic hematopoietic SCT in Korea based on high-resolution HLA typing for HLA-A, -B and DRB1. The blue line is the probability of 4/6 antigen matching and with maximum and minimum possibilities (dotted line). The red line is the probability of 5/6 antigen matching. The black line is the probability of 6/6 antigen matching. Cord blood inventory 10000 1e+05 5e+05 Figure 2 . The probability of finding matched CBU based on increasing inventory size (10-500 000) from 701 507 hypothetical donor types for 2450 patients who received or were awaiting unrelated allogeneic hematopoietic SCT in Korea based on low-resolution HLA typing for HLA-A and B and high-resolution HLA typing for HLA-DRB1. The blue line is the probability of 4/6 antigen matching and with maximum and minimum possibilities (dotted line). The red line is the probability of 5/6 antigen matching. The black line is the probability of 6/6 antigen matching.
donors with the probabilities of 80%. In the United Kingdom, approximately 50 000 CBUs are needed for 2000 active patients, and 79.5% find at least one donor in a 5/6 setting. 12 This reflects the lower heterogeneity of HLA among Koreans.
The estimation of inventory size required is also related to the resolution of HLA typing. In previous studies on appropriate CB inventory size, low-resolution HLA typing was used. 6, 12, 13 With high-resolution typing, an increased heterogeneity of HLA resulted in a larger inventory size. For high-resolution typing of HLA-A, B and DRB1, we required a CB inventory that was twofold larger than the one used for high-resolution typing of HLA-DRB1 only (94.6% probability with 100 000 CBUs versus 95.0% with 50 000 CBUs in a 5/6 match). This remarkable increase in the size of CB inventory might be related to the higher heterogeneity of HLA-A and B alleles than of HLA-DRB1 alleles. 14 The estimated required inventory size based on the highresolution typing of HLA-DRB1 only was similar to that observed in our previous report, 14 which was based on low-resolution typing (50 000 versus 51 000 CBUs with same 95% probability and 5/6 matching, respectively). In contrast to our previous report, the present study included patients who had already received allogeneic hematopoietic SCT as well as those who were awaiting it, resulting in a decreased bias for common HLA types in Korean patients. Instead of using the theoretical haplotypes with a frequency of ⩾ 0.0001% (with a coverage of 99% Koreans) as in our previous report, this study used estimated haplotypes with a frequency of ⩾ 0.00695% (1/(7690 2) with a coverage of 97.5% Koreans) and that resulted in a decreased inventory size.
High-resolution matching might improve the transplantation outcome in BM or PBSC transplantation 15, 16 as well as CBT.
7,17
Kurtzberg et al. reported that the hazard risk for patients with a ⩽ 4/6 match increased after retrospective high-resolution analysis of HLA-A and B as well as HLA-DRB1 compared with lowresolution analysis of HLA-A and B. Koreans show more allelic diversity, particularly in HLA-A*02 (gene frequency of 12.6%), as compared with Caucasians, which causes higher frequencies of mismatches at the allele level. This mismatch may result in a poor clinical outcome in hematopoietic SCTs, as reported previously. 16 Another issue on HLA typing is the importance of HLA-C locus in CBT. 18 CBT with a mismatch at HLA-C raised transplantationrelated mortality risk. The allele level mismatching including the locus HLA-A was recently reported increasing nonrelapse mortality. 19 Therefore, despite more generosity in HLA matching of CBT, 20 high-resolution HLA typing (with sufficient financial support) including the HLA-C locus needs to be introduced in public CB banks. The policy change for the inventory on HLAtyping resolution may cause re-estimation of required CB bank inventory size. For example, much more than 50 000 donor units are needed for 80% of patients at 5/6 matching (HLA-A,-B low and HLA-DRB1 high resolutions) in the UK, 12 or much more than 10 000 units are needed for 96% of patients at 5/6 matching level (the Ag level for HLA-A, -B and -DR) in Japan. 13 In conclusion, we estimated the CB inventory size based on a large number of stored CBUs and patients who were tested for allogeneic hematopoietic SCT under various matching conditions with high-resolution typing of HLA-A, B and DRB1 in Korea. The findings can be used to help public entities evaluate storage resources for CBUs for patients who are awaiting CBT.
